🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →
Browsing Tag

Doximity Scribe

1 post
Read More

Doximity (NYSE: DOCS) shares surge 55% as clinical AI adoption transforms the earnings story despite weaker profit

Doximity shares surged after fiscal Q1 revenue beat expectations and clinical AI engagement accelerated, even though earnings, free cash flow and EBITDA declined. The reaction suggests investors are beginning to value Doximity less as a physician advertising platform and more as a potential clinical AI infrastructure company.